Growing evidence suggests that T cells may play a critical role in combating severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, COVID-19 vaccines that can …

Abstract SARS-CoV-2, which causes COVID-19, was first identified in humans in late 2019
and is a coronavirus which is zoonotic in origin. As it spread around the world there has …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the
ongoing pandemic of coronavirus disease 2019 (COVID-19), a public health emergency of …

We present a combinatorial machine learning method to evaluate and optimize peptide
vaccine formulations for SARS-CoV-2. Our approach optimizes the presentation likelihood of …

Background Burkholderia pseudomallei is an infectious agent causing severe disease
melioidosis resulting in pneumonia, fever, and acute septicemia in humans. B. pseudomallei …

Background With the diffusion of SARS-CoV-2 around the world, human health is being
threatened. As there is no effective vaccine yet, the development of the vaccine is urgently in …

The purpose of this study is to monitor specific anti-severe acute respiratory syndrome
coronavirus 2 (anti-SARS-CoV-2) IgG and IgM antibody production in patients with severe …

Arenaviral infections often result lethal hemorrhagic fevers, affecting primarily in African and
South American regions. To date, there is no FDA-approved licensed vaccine against …

The emergence of COVID19 pandemic caused by SARS-CoV-2 virus has created a global
public health and socio-economic crisis. Immunoinformatics-based approaches to …

Abstract The 2019 Novel Coronavirus (SARS-CoV-2) has infected millions of people
worldwide and caused millions of deaths. The virus has gone numerous mutations to …